عربــى

EGX 30 13,493.69 -0.94%



Memphis Pharmaceutical losses widen to LE13 m ending Sept 2018

Memphis Pharmaceutical losses widen to LE13 m ending Sept 2018

Arab Finance: Memphis Pharmaceutical (MPCI) announced in a statement sent to EGX, the audited financial results for the fiscal period starting July 1, 2018, and ending September 30, 2018.

The company incurred net losses of LE12,932,118, versus net losses of LE7,806,711 in the same period a year ago. 

All rights reserved to Arab Finance 2015 ©

Back to top